{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:17:11Z","timestamp":1780474631013,"version":"3.54.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jbspin.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T19:00:11Z","timestamp":1523041211000},"page":"185-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management"],"prefix":"10.1016","volume":"86","author":[{"given":"Cyrille B.","family":"Confavreux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Pialat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Belli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Brevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Decroisette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Tescaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Wegrzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Barrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Mornex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Souquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2018.03.005_bib0345","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1056\/NEJMra0805239","article-title":"Molecular basis of metastasis","volume":"359","author":"Chiang","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2012.10.005","article-title":"SnapShot: bone metastasis","volume":"151","author":"Ell","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0355","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jbspin.2017.05.006","article-title":"Pathophysiology of bone metastases from solid malignancies","volume":"84","author":"Clezardin","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0360","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0365","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0370","first-page":"576","article-title":"Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601)","volume":"6","author":"Decroisette","year":"2011","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0375","unstructured":"Confavreux C, Barrey C, Belliere A, et al. [Guidelines on Bone Metastases: 2017 Update]. ARISTOT; 2017 [French]. n.d."},{"key":"10.1016\/j.jbspin.2018.03.005_bib0380","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/bonekey.2014.75","article-title":"Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC)","volume":"3","author":"Confavreux","year":"2014","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0385","article-title":"Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Novello","year":"2016","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12253-013-9667-4","article-title":"The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma","volume":"20","author":"Krawczyk","year":"2014","journal-title":"Pathol Oncol Res POR"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0395","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1002\/cncr.27409","article-title":"Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer","volume":"118","author":"Doebele","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0400","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bone.2018.01.004","article-title":"Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers","volume":"108","author":"Chambard","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0405","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1038\/srep39721","article-title":"KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis","volume":"7","author":"Lohinai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0410","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.acra.2016.03.017","article-title":"Imaging for the pretreatment staging of small cell lung cancer: a systematic review","volume":"23","author":"Mitchell","year":"2016","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0415","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2017.12.012","article-title":"Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group","volume":"91","author":"deSouza","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0420","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/radiol.2017162336","article-title":"Dynamic contrast-enhanced MR imaging parameters in bone metastases from non-small cell lung cancer: comparison between lesions with and lesions without epidermal growth factor receptor mutation in primary lung cancer","volume":"284","author":"Kim","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0425","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1158\/1538-7445.AM2016-2890","article-title":"Usefulness of dynamic contrast-enhanced magnetic resonance imaging for predicting treatment response to vinorelbine-cisplatin with or without recombinant human endostatin in bone metastasis of non-small cell lung cancer","volume":"6","author":"Zhang","year":"2016","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0430","doi-asserted-by":"crossref","first-page":"e0153840","DOI":"10.1371\/journal.pone.0153840","article-title":"Inter- and intra-observer repeatability of quantitative whole-body, diffusion-weighted imaging (WBDWI) in metastatic bone disease","volume":"11","author":"Blackledge","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0435","first-page":"275","article-title":"Economic benefits and diagnostic quality of diffusion-weighted magnetic resonance imaging for primary lung cancer","volume":"23","author":"Usuda","year":"2017","journal-title":"Ann Thorac Cardiovasc Surg Off J Assoc Thorac Cardiovasc Surg Asia"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0440","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2004.09.053","article-title":"American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003","volume":"22","author":"Pfister","year":"2004","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0445","first-page":"491","article-title":"Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survival","volume":"5","author":"Pluquet","year":"2010","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0450","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00259-009-1181-2","article-title":"Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET\/CT","volume":"36","author":"Kr\u00fcger","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0455","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s002590050291","article-title":"Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer","volume":"25","author":"Bury","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0460","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2214\/ajr.182.5.1821129","article-title":"False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications","volume":"182","author":"Cheran","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0465","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.crad.2006.09.015","article-title":"PET\/CT in non-small cell lung cancer staging-promises and problems","volume":"62","author":"Devaraj","year":"2007","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0470","first-page":"26","article-title":"Comparison of bone and 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in the evaluation of bony metastases in lung cancer","volume":"5","author":"Gayed","year":"2003","journal-title":"Mol Imaging Biol MIB Off Publ Acad Mol Imaging"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0475","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3346\/jkms.2009.24.2.275","article-title":"The role of whole-body FDG PET\/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer","volume":"24","author":"Min","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0480","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.lungcan.2008.12.004","article-title":"Efficacy comparison between (18)F-FDG PET\/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer","volume":"65","author":"Song","year":"2009","journal-title":"Lung Cancer Amst Neth"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0485","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ctrv.2010.04.003","article-title":"Metastasis and bone loss: advancing treatment and prevention","volume":"36","author":"Coleman","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0490","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/jnci\/djs263","article-title":"Effects of bone-targeted agents on cancer progression and mortality","volume":"104","author":"Coleman","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0495","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0500","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","article-title":"Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial\u2014the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group","volume":"21","author":"Rosen","year":"2003","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0505","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0510","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cncr.23529","article-title":"Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid","volume":"113","author":"Lipton","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0515","first-page":"1823","article-title":"Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study","volume":"7","author":"Scagliotti","year":"2012","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0520","first-page":"859","article-title":"Increasing osteoblastic lesions as a manifestation of a major response to gefitinib","volume":"1","author":"Garfield","year":"2006","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0525","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2010.04.003","article-title":"Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases","volume":"71","author":"Sun","year":"2011","journal-title":"Lung Cancer Amst Neth"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0530","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1101\/gad.1824809","article-title":"ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis","volume":"23","author":"Lu","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0535","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bone.2010.03.001","article-title":"Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis","volume":"46","author":"Canon","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0540","doi-asserted-by":"crossref","first-page":"42979","DOI":"10.1038\/srep42979","article-title":"Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0545","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3816\/CLC.2004.n.030","article-title":"Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications","volume":"6","author":"Hirsh","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0550","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3816\/SCT.2007.n.003","article-title":"Treatment of bone metastases and bone pain with bisphosphonates","volume":"4","author":"Lipton","year":"2007","journal-title":"Support Cancer Ther"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0555","first-page":"1280","article-title":"Bisphosphonate use in patients with lung cancer and bone metastases: recommendations of a European expert panel","volume":"4","author":"De Marinis","year":"2009","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0560","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.lpm.2011.04.001","article-title":"La vitamine D chez l\u2019adulte: recommandations du GRIO","volume":"40","author":"Benhamou","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0565","first-page":"152","article-title":"Managing patients with therapeutic antibodies in odontostomatology","volume":"115","author":"Demoersman","year":"2014","journal-title":"Rev Stomatol Chir Maxillo-Faciale Chir Orale"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0570","first-page":"413","article-title":"Osteonecrosis of the jaw and bisphophonates in oncology","volume":"95","author":"Facon","year":"2008","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0575","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0580","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.revmed.2010.11.007","article-title":"Guide de recommandations d\u2019utilisation des bisphosphonates dans les l\u00e9sions osseuses malignes des tumeurs solides et du my\u00e9lome multiple","volume":"32","author":"Brantus","year":"2011","journal-title":"Rev M\u00e9decine Interne"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0585","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0590","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0595","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jbspin.2017.05.005","article-title":"Vertebroplasty and interventional radiology procedures for bone metastases","volume":"85","author":"Laredo","year":"2018","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0600","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1148\/radiology.200.2.8685351","article-title":"Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up","volume":"200","author":"Cotten","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0605","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.diii.2016.12.005","article-title":"Percutaneous osteosynthesis and cementoplasty for stabilization of malignant pathologic fractures of the proximal femur","volume":"98","author":"Mavrovi","year":"2017","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0610","first-page":"647","article-title":"Therapeutic percutaneous injections in the treatment of malignant acetabular osteolyses","volume":"19","author":"Cotten","year":"1999","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0615","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00256-004-0776-8","article-title":"Complications of percutaneous vertebroplasty and their prevention","volume":"33","author":"Laredo","year":"2004","journal-title":"Skeletal Radiol"},{"issue":"Suppl","key":"10.1016\/j.jbspin.2018.03.005_bib0620","first-page":"S227","article-title":"Radiotherapy of bone metastases","volume":"20","author":"Thureau","year":"2016","journal-title":"Cancer Radiother J Soc Francaise Radiother Oncol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0625","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2007.11.075","article-title":"The radiation dose-response of the human spinal cord","volume":"71","author":"Schultheiss","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0630","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1016\/j.ijrobp.2010.11.056","article-title":"Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors","volume":"81","author":"Rades","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0635","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ijrobp.2010.01.024","article-title":"Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression","volume":"79","author":"Rades","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0640","first-page":"342","article-title":"Hypofractionated stereotactic radiotherapy of bone metastases","volume":"18","author":"Pichon","year":"2014","journal-title":"Cancer Radiother J Soc Francaise Radiother Oncol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0645","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2013.07.023","article-title":"Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors","volume":"82","author":"Griffioen","year":"2013","journal-title":"Lung Cancer Amst Neth"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0650","first-page":"1547","article-title":"Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (NCT01282450)","volume":"7","author":"De Ruysscher","year":"2012","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0655","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s000660050061","article-title":"Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3Gy vs. 1 time 8Gy). A prospective study","volume":"175","author":"Koswig","year":"1999","journal-title":"Strahlenther Onkol Organ Dtsch R\u00f6ntgenges Al"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0660","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2016.03.025","article-title":"Comparison of patient-reported outcomes with single versus multiple fraction palliative radiotherapy for bone metastasis in a population-based cohort","volume":"119","author":"Conway","year":"2016","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0665","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.canrad.2014.05.007","article-title":"Combination of stereotactic irradiation and chemotherapy or targeted therapies: state of the art and preliminary recommendations","volume":"18","author":"Thariat","year":"2014","journal-title":"Cancer Radioth\u00e9r J Soc Fr Radioth\u00e9r Oncol"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0670","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003086-198912000-00027","article-title":"Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures","author":"Mirels","year":"1989","journal-title":"Clin Orthop"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0675","first-page":"120","article-title":"Predicting pathologic fracture risk in the management of metastatic bone defects","author":"Hipp","year":"1995","journal-title":"Clin Orthop"},{"key":"10.1016\/j.jbspin.2018.03.005_bib0680","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group","volume":"35","author":"Fisher","year":"2010","journal-title":"Spine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18300484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18300484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:24:24Z","timestamp":1761150264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X18300484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1297319X18300484"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.03.005","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}